This finding is supported by data from the Caucasian and Asian NSCLC cohorts, which were found to have a range from 0.9% to 4.0% of MET variants using whole-exome sequencing and the Ion AmpliSeqTM Library Kit 2.0, respectively [42,43]. The gene discussed is MET; the disease is non-small cell lung carcinoma.